87 related articles for article (PubMed ID: 11673391)
1. Plasma islet amyloid polypeptide is not an effective tumor marker for pancreatic cancer even when protease inhibitors and rapid freezing of specimens are utilized.
Tateishi K; DiMagno EP; Klee GG
Clin Chem; 2001 Nov; 47(11):2071-3. PubMed ID: 11673391
[No Abstract] [Full Text] [Related]
2. Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer.
Chari ST; Klee GG; Miller LJ; Raimondo M; DiMagno EP
Gastroenterology; 2001 Sep; 121(3):640-5. PubMed ID: 11522748
[TBL] [Abstract][Full Text] [Related]
3. The use of chromogranin, synaptophysin and islet amyloid polypeptide as markers for neuroendocrine tumours.
Stridsberg M
Ups J Med Sci; 1995; 100(3):169-99. PubMed ID: 8808182
[No Abstract] [Full Text] [Related]
4. The specificity of amylin for the diagnosis of pancreatic adenocarcinoma.
Brand RE; Ding XZ; Young CM; Adrian TE
Int J Gastrointest Cancer; 2002; 31(1-3):123-8. PubMed ID: 12622423
[TBL] [Abstract][Full Text] [Related]
5. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes.
Permert J; Larsson J; Westermark GT; Herrington MK; Christmanson L; Pour PM; Westermark P; Adrian TE
N Engl J Med; 1994 Feb; 330(5):313-8. PubMed ID: 8277951
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse.
D'Alessio DA; Verchere CB; Kahn SE; Hoagland V; Baskin DG; Palmiter RD; Ensinck JW
Diabetes; 1994 Dec; 43(12):1457-61. PubMed ID: 7958499
[TBL] [Abstract][Full Text] [Related]
7. Lipid accelerating the fibril of islet amyloid polypeptide aggravated the pancreatic islet injury in vitro and in vivo.
Mo XD; Gao LP; Wang QJ; Yin J; Jing YH
Lipids Health Dis; 2018 Mar; 17(1):42. PubMed ID: 29523142
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer in rats and hamsters does not induce IAPP-related hyperglycaemia.
Oosterwijk C; van Hulst KL; Visser CJ; Woutersen RA; Lips CJ; van den Tweel JG; Höppener JW
Int J Cancer; 1997 Aug; 72(4):637-41. PubMed ID: 9259404
[TBL] [Abstract][Full Text] [Related]
9. Islet-amyloid polypeptide in human plasma.
van Jaarsveld BC; Hackeng WH; Nieuwenhuis MG; Erkelens DW; Geerdink RA; Lips CJ
Lancet; 1990 Jan; 335(8680):60. PubMed ID: 1967373
[No Abstract] [Full Text] [Related]
10. [Islet amyloid polypeptide (IAPP)].
Sanke T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():545-7. PubMed ID: 16149573
[No Abstract] [Full Text] [Related]
11. Islet amyloid polypeptide and calcitonin gene-related peptide immunoreactivity in amyloid and tumor cells of canine pancreatic endocrine tumors.
O'Brien TD; Westermark P; Johnson KH
Vet Pathol; 1990 May; 27(3):194-8. PubMed ID: 1972303
[TBL] [Abstract][Full Text] [Related]
12. Early changes in islet hormone secretion in the hamster pancreatic cancer model.
Permert J; Herrington M; Kazakoff K; Pour PM; Adrian TE
Teratog Carcinog Mutagen; 2001; 21(1):59-67. PubMed ID: 11135321
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
Br J Cancer; 1994 Mar; 69(3):562-5. PubMed ID: 8123488
[TBL] [Abstract][Full Text] [Related]
14. Amyloid protein in somatostatinoma differs from human islet amyloid polypeptide.
Ohsawa H; Kanatsuka A; Tokuyama Y; Yamaguchi T; Makino H; Yoshida S; Horie H; Mikata A; Kohen Y
Acta Endocrinol (Copenh); 1991 Jan; 124(1):45-53. PubMed ID: 2000701
[TBL] [Abstract][Full Text] [Related]
15. On the role of islet amyloid polypeptide in glucose intolerance and anorexia of pancreatic cancer.
Herrington MK; Arnelo U; Permert J
Pancreatology; 2001; 1(3):267-74. PubMed ID: 12120206
[No Abstract] [Full Text] [Related]
16. Islet amyloid polypeptide, a novel pancreatic peptide, is a circulating hormone secreted under glucose stimulation.
Nakazato M; Miyazato M; Asai J; Mitsukawa T; Kangawa K; Matsuo H; Matsukura S
Biochem Biophys Res Commun; 1990 Jun; 169(2):713-8. PubMed ID: 2357227
[TBL] [Abstract][Full Text] [Related]
17. Morphometric studies in human pancreatic cancer argues against the etiological role of type 2 diabetes in pancreatic cancer.
Saruc M; Iki K; Pour PM
Histol Histopathol; 2010 Apr; 25(4):423-32. PubMed ID: 20183795
[TBL] [Abstract][Full Text] [Related]
18. [Quantification of plasma DNA as a tumor marker in patients with pancreatic cancer].
Lee KH; Yoon WJ; Lee JK; Ryu JK; Kim YT; Yoon YB
Korean J Gastroenterol; 2005 Sep; 46(3):226-32. PubMed ID: 16179843
[TBL] [Abstract][Full Text] [Related]
19. Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model.
Höppener JW; Oosterwijk C; Nieuwenhuis MG; Posthuma G; Thijssen JH; Vroom TM; Ahrén B; Lips CJ
Diabetologia; 1999 Apr; 42(4):427-34. PubMed ID: 10230646
[TBL] [Abstract][Full Text] [Related]
20. Elevated fasting plasma level of islet amyloid polypeptide (IAPP) in chronic alcoholic pancreatitis (CAP).
Gasiorowska A; Orszulak-Michalak D; Kozlowska A; Malecka-Panas E
Hepatogastroenterology; 2003; 50(49):258-62. PubMed ID: 12630035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
